It's time to maintain a thorough traceable excipient trail.
Arthur J. Falk, PhD
Advertisement
Arthur J. Falk, PhD, is president and CDO of International Pharmaceutical Excipient Auditing (IPEA).
Articles by Arthur J. Falk, PhD
Securing the integrity of the excipient supply chain is a crucial task in ensuring the overall pharmaceutical supply chain. The authors outline excipient-control strategies and practices for the manufacture, distribution, and receipt of excipients.
Two FDA final rules issued in response to the Bioterrorism Response Act of 2002 may significantly affect the supply and importation of pharmaceutical excipients.
Advertisement
Latest Updated Articles
- Inside IPEC: Excipient Pedigree as a Supply Chain Tool
Published: March 2nd 2010 | Updated:
Excipient-Control StrategiesPublished: October 1st 2008 | Updated:
- The Bioterrorism Act
Published: January 2nd 2004 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
2
AI and Human Collaboration Essential for Bio/pharma Innovation
3
Sustainability and Stability in Excipients
4
Centralizing AI Strategy, Ensuring Process Integrity, and Balancing Quick Wins with Long-Term Drug Design in Bio/pharma
5
